hansaben arvindbhai patel's most recent trade in Lincoln Pharmaceuticals Ltd. was a Acquisition of 60,000 Equity Shares done at an average price of Rs. 348.3 . Disclosure was reported to the exchange on March 22, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
hansaben arvindbhai patel's has made SAST transactions in Lincoln Pharmaceuticals Ltd. recently where a Acquisition of 60,000 shares done . Disclosure was reported to the exchange on March 22, 2023.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lincoln Pharma | Hansaben Arvindbhai Patel | Other | Acquisition | 24 Mar 2023 | 60,000 | - | 0.30% | - | 21 Mar 2023 01 Jan 1900 |
SAST (10(6)) | - | - | |
Lincoln Pharma | Hansaben Arvindbhai Patel | Promoter | Acquisition | 24 Mar 2023 | 60,000 | 177,200 (0.89%) | 0.30% | - | 21 Mar 2023 21 Mar 2023 |
SAST (29(2)) | - | Inter-se Transfer | |
Lincoln Pharma | Hansaben Arvindbhai Patel | Promoter Group | Acquisition | 22 Mar 2023 | 60,000 | 177,200 (0.89%) | 0.30% | 348.3 | 20,895,000 | 21 Mar 2023 21 Mar 2023 |
Insider Trading | Equity Shares | Inter-se Transfer |
Lincoln Pharma | Hansaben Arvindbhai Patel | Promoter | Acquisition | 21 Feb 2023 | 60,000 | - | 0.30% | - | 23 Feb 2023 23 Feb 2023 |
SAST (10(1)(a)) | - | None |